Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics … Read more
Quest Diagnostics Incorporated - Asset Resilience Ratio
Quest Diagnostics Incorporated (DGX) has an Asset Resilience Ratio of 2.59% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Quest Diagnostics Incorporated's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Quest Diagnostics Incorporated's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $420.00 Million | 2.59% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $420.00 Million | 2.59% |
Asset Resilience Insights
- Limited Liquidity: Quest Diagnostics Incorporated maintains only 2.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Quest Diagnostics Incorporated Industry Peers by Asset Resilience Ratio
Compare Quest Diagnostics Incorporated's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Quest Diagnostics Incorporated (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Quest Diagnostics Incorporated.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.59% | $420.00 Million | $16.23 Billion | -0.81pp |
| 2024-12-31 | 3.40% | $549.00 Million | $16.15 Billion | -1.49pp |
| 2023-12-31 | 4.89% | $686.00 Million | $14.02 Billion | +2.44pp |
| 2022-12-31 | 2.45% | $315.00 Million | $12.84 Billion | -4.28pp |
| 2021-12-31 | 6.73% | $916.00 Million | $13.61 Billion | -5.24pp |
| 2020-12-31 | 11.97% | $1.68 Billion | $14.03 Billion | +2.69pp |
| 2019-12-31 | 9.28% | $1.19 Billion | $12.84 Billion | +8.05pp |
| 2018-12-31 | 1.23% | $135.00 Million | $11.00 Billion | -0.08pp |
| 2017-12-31 | 1.30% | $137.00 Million | $10.50 Billion | -2.25pp |
| 2016-12-31 | 3.55% | $359.00 Million | $10.10 Billion | -- |
| 2015-12-31 | 0.00% | $0.00 | $9.96 Billion | -- |
| 2014-12-31 | 0.00% | $0.00 | $9.88 Billion | -- |
| 2013-12-31 | 0.00% | $0.00 | $8.95 Billion | -- |
| 2012-12-31 | 0.00% | $0.00 | $9.28 Billion | -- |
| 2011-12-31 | 0.00% | $0.00 | $9.31 Billion | -- |
| 2010-12-31 | 0.00% | $0.00 | $8.53 Billion | -- |
| 2009-12-31 | 0.00% | $0.00 | $8.56 Billion | -- |